Sword Diagnostics, Inc. , committed to improving healthcare through the use of innovative detection technology, recently relocated its corporate headquarters and 
research facilities to accommodate planned growth. Double the size of its previous space in the suburbs, Sword’s new location at University Technology Park at IIT (UTP) in Chicago marks its shift from start-up venture to growth-stage commercial entity.
Sword launched its proprietary biological detection system in January 2010, closely following the issuance of the company’s core patent. Developed for ultra-sensitive immunoassays, the technology allows greater sensitivity and improved accuracy in disease marker testing, without increasing cost or complexity. Such performance enhancements accelerate gains in basic and clinical research, drug discovery, and clinical diagnostics development, leading to advancements in disease detection.
"This is an important milestone for our company,” said Sword Diagnostics President Dave Dingott. "Our new facility at UTP not only offers more space, better working conditions for the team and access to university resources, but moving from suburban Chicago into the city also improves Sword’s ability to attract top talent with its metropolitan location – all key factors in our continued growth.
"The UTP lease allows us to expand into adjacent suites as the need arises without prematurely incurring costs. Wexford’s flexibility and willingness to partner with its tenants is critically important to high growth-stage companies like Sword Diagnostics.”
"Sword is a great example of the type of life science company that the Technology Business Center within UTP is designed for and dedicated to supporting,” said Catherine E. Vorwald, director of business development for Wexford Science + Technology, LLC. "UTP and IIT are able to offer Sword the resources, expertise, and environment it will need to grow and expand for many years to come. We are proud to add Sword to our growing roster of UTP tenants.”
